Effectiveness and safety of the monoclonal antibody drug lecanemab (Leqembi) in reducing beta-amyloid plaques in alzheimer’s dementia: a literature review. Journal of Health Management and Pharmacy Exploration, v. 3, n. 1, 27 febr.2025.